SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $294,000 | -59.6% | 2,096 | -38.2% | 0.00% | -75.0% |
| Q2 2019 | $727,000 | +19.4% | 3,392 | +1.5% | 0.00% | +33.3% |
| Q1 2019 | $609,000 | +164.8% | 3,342 | +43.2% | 0.00% | +200.0% |
| Q4 2018 | $230,000 | +1.8% | 2,333 | +61.7% | 0.00% | 0.0% |
| Q3 2018 | $226,000 | +7.6% | 1,443 | +26.6% | 0.00% | 0.0% |
| Q2 2018 | $210,000 | -24.7% | 1,140 | -76.2% | 0.00% | -50.0% |
| Q4 2015 | $279,000 | – | 4,789 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |